Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Linda Cook to Triple Negative Breast Neoplasms

This is a "connection" page, showing publications Linda Cook has written about Triple Negative Breast Neoplasms.

 
Connection Strength
 
 
 
0.703
 
  1. Chen L, Li CI, Tang MT, Porter P, Hill DA, Wiggins CL, Cook LS. Reproductive Factors and Risk of Luminal, HER2-Overexpressing, and Triple-Negative Breast Cancer Among Multiethnic Women. Cancer Epidemiol Biomarkers Prev. 2016 09; 25(9):1297-304.
    View in: PubMed
    Score: 0.391
  2. Lorona NC, Cook LS, Tang MC, Hill DA, Wiggins CL, Li CI. Recent Use of Oral Contraceptives and Risk of Luminal B, Triple-Negative, and HER2-Overexpressing Breast Cancer. Horm Cancer. 2019 06; 10(2-3):71-76.
    View in: PubMed
    Score: 0.119
  3. Chen L, Cook LS, Tang MT, Porter PL, Hill DA, Wiggins CL, Li CI. Body mass index and risk of luminal, HER2-overexpressing, and triple negative breast cancer. Breast Cancer Res Treat. 2016 06; 157(3):545-54.
    View in: PubMed
    Score: 0.097
  4. Swede H, Sarwar A, Magge A, Braithwaite D, Cook LS, Gregorio DI, Jones BA, R Hoag J, Gonsalves L, L Salner A, Zarfos K, Andemariam B, Stevens RG, G Dugan A, Pensa M, A Brockmeyer J. Mortality risk from comorbidities independent of triple-negative breast cancer status: NCI-SEER-based cohort analysis. Cancer Causes Control. 2016 May; 27(5):627-36.
    View in: PubMed
    Score: 0.096
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)